QSI

Quantum-Si incorporated

$1.28

-6.57%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.

Source: Yahoo Finance
AI summary

Price & performance

1M-16.1%
3M+74.3%
YTD+12.1%
1Y-35.0%
52-week range—
Beta2.71
Full chart and returns against a benchmark

Q-Score

45/ 100

Quality against peers; 50 is the peer median.

Growth34
Risk36
Performance67
Valuation45
Profitability32
Leverage70
Sentiment62
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$2.4M-20.3%
Net income-$101.3M
Net margin—
Historical fundamentals

Red flags in filings

1active red flag
Exchange listing noticeJul 24, 2026
Filings, findings and the timeline

Revenue exposure

71%of revenue from outside the US
Non-US71%
United States29%
Regions, segments, customers and suppliers

Valuation

QSIIndustryP/E—29.61P/S—3.49EV/EBITDA—18.38P/B1.763.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 5next report
EPS estimate$-0.12
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate